60491-16-9

Upstream product

• 141-82-2 malonic acid 
• 25016-01-7 5-bromo-2-methoxybenzaldehyde 
• 1443430-29-2 (E)-3-(5-bromo-2-methoxyphenyl)-1-(1-hydroxynaphthalen-2-yl)prop-2-en-1-one 
• 861324-72-3 3-methoxy-3-(2-methoxy-phenyl)-propionic acid 
• 7647-01-0 hydrogenchloride 
• 861324-40-5 3-(5-bromo-2-methoxy-phenyl)-3-methoxy-propionic acid 

Downstream Products

• 2476-35-9 5-bromo-2-methoxybenzoic acid 
• 389890-69-1 (E)-3-(5-Bromo-2-methoxy-phenyl)-N-{2-[4-(4-chloro-benzoyl)-piperidin-1-yl]-ethyl}-acrylamide 

Relevant academic research and scientific papers

Development of flavonoid-based inverse agonists of the key signaling receptor US28 of human cytomegalovirus

A series of 31 chalcone- and flavonoid-based derivatives were synthesized in good overall yields and screened for their inverse agonist activity on the US28 receptor of human cytomegalovirus (HCMV). With one exception (e.g., 2-(5-bromo-2-methoxyphenyl)-3-hydroxy-4H-chromen-4-one), halogen-substituted flavonoids were typically more potent inverse agonists than their related hydro derivatives. While toxicity could be used to partially explain the inverse agonist activity of some members of the series, 5-(benzyloxy)-2-(5-bromo-2- methoxyphenyl)-4H-chromen-4-one (11b) acted on the US28 receptor as a nontoxic, inverse agonist. The full inverse agonism (efficacy, -89%) and potency (EC 50 = 3.5 μM) observed with flavonoid 11b is especially important as it provides both a new tool to study US28 signaling and a potential platform for the future development of HCMV-targeting drugs.